Login / Signup

Pathological findings in central nervous system demyelination associated with infliximab.

Alicja Kalinowska-LyszczarzMahboobeh Fereidan-EsfahaniYong GuoClaudia F LucchinettiWilliam Oliver Tobin
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)
Infliximab treatment is associated with CNS inflammatory demyelinating activity, which is histopathologically indistinguishable from MS.
Keyphrases
  • ulcerative colitis
  • mass spectrometry
  • multiple sclerosis
  • oxidative stress
  • cerebrospinal fluid